Agenda
Plenary Sessions
The Digital Lab
The Connected Lab
The Innovation Lab
09:00
Keynote Address: Research Technologies Driving Collaborative Innovation
Plenary Sessions
09:00
Lene Oddershede, Senior Vice President, Novo Nordisk Foundation
Keynote Address: Scientific Orchestration and Data Platforms: This is what science needs
Plenary Sessions
09:00
Richard Milne, Vice President & General Manager, Digital Science Solutions, Thermo Fisher Scientific

The challenges of the analytical space are clear. Organizational barriers often make it difficult for scientists to collaborate and leverage their most important asset – data. The Thermo Fisher Connect Platform breaks down these barriers to connect people, instruments, and systems. This begins with integration to the data created through analytical techniques. The Thermo Scientific Ardia Platform connects IC, GC, LC and MS data, to provide a holistic view and enable deeper analysis, providing scientists a clearer path to the next significant breakthrough. Since scientists don’t operate alone, it’s crucial to connect scientific data with production, operational and other enterprise data. Thermo Fisher Connect is the conduit between the lab and the enterprise.

09:50
Keynote Address: Sanofi R&D Hub Strategy and Collaborative Innovation
Plenary Sessions
09:50
Jochen Maas, Head of R&D, Sanofi
10:40
Coffee Break & Exhibition
Plenary Sessions
10:40
11:20
Application of State-of-the-Art Data and Digital Technologies to Develop, Supply and Launch Innovative Medicines
The Digital Lab
11:20
Vijay Raju, VP, Global Head of Analytical R&D, Novartis
Revolutionising Laboratory Data Capture to Power Data Analytics
The Connected Lab
11:20
Penny Smee, Director & Senior Product Owner, GSK
The Path to a Modern Research Laboratory – tales from the trenches
The Innovation Lab
11:20
Brian Gilman, VP Research Technology, Vertex

The Path to a Modern Research Laboratory – tales from the trenches

Smarten Up the Lab: Facilitating Experiment Design & Data Management
The Innovation Lab
11:20
Vasu Rangadass, President & CEO, L7 Informatics
Victoria Lee, Senior Global Product Manager, QIAGEN
12:20
Digitalisation & the Lab of the Future
The Digital Lab
12:20
Rainer Winnenberg, Team Lead Literature-based Scientific Discovery - FAIR Data, AbbVie

Generating FAIR Lab Data at AbbVie
Rainer Winnenburg, Team Lead Literature-based Scientific Discovery – FAIR Data, AbbVie

Data Assets: Driving Sustainable Business Transformation in Labs
The Connected Lab
12:20
Ralph Häfeli, Head Strategic Business Partnering, Technical R&D, Novartis

Ralph Häfeli, Head Strategic Business Partnering, Technical R&D,

The Good, the Bad and the Ugly: The Three Faces of Digital Collaboration in Drug Design
The Innovation Lab
12:20
Fabio Rancati, Lead Optimization Unit Head, Chiesi Farmaceutici

Fabio Rancati Lead Optimization Unit Head , Chiesi Farmaceutici

The Dramatic Benefits of Digitalized Experiments
The Innovation Lab
12:20
Markus Gershater, Chief Scientific Officer, Synthace

The digital world has immense potential to transform the value we get from experiments. Digitalization efforts often focus on how we can gather and structure experiment data and metadata so that companies can make best use of the information that they’re continually producing. However, this invariably leads to a misalignment: the company needs highly structured and standardized data with as much contextual metadata as possible, while -due to time pressures- the scientist wants to just gather the data and context required to draw immediate conclusions and move on. This misalignment means that (meta)data will rarely be recorded in sufficient detail to get anything but the most immediate value.

13:20
Lunch & Exhibition
Plenary Sessions
13:20
14:20
High Dimensional Data Analysis – applications in drug discovery and clinical trials
The Digital Lab
14:20
Yann Abraham, Principal Scientist, Janssen
The Application of AI/ML to Drive Innovation in Lab
The Digital Lab
14:20
Djork-Arné Clevert, Head of Machine Learning Research, Bayer
Delivering the Lab of the Future
The Connected Lab
14:20
Phil Williams, Programme Manager, Early Science, R&D IT, AstraZeneca
  • Proving the Concept with Lab4Life – AstraZeneca
  • Piloting with Digital Lab – AstraZeneca
  • Putting into Practice with Oligonucleotides – AstraZeneca
  • Delivering the Impossible with The National Covid-19 Test Centre – GlaxoSmithKline, University of Cambridge and AstraZeneca
Accelerating Decision Making Through Parallel Medicinal Chemistry
The Connected Lab
14:20
Francesco Rianjongdee, Scientific Leader, GSK
The Lab of the Future at Roche Pharma – creating a physical infrastructure that supports scientific innovation
The Innovation Lab
14:20
Geo Adam, Global Head of pRED Facilities & Infrastructure Projects, Roche
Lab of the future (pt. 2) – The role of R&D in the transformative journey
The Innovation Lab
14:20
Mark McCord-Amasis, Vice President, Real Estate & Facilities, Seagen
  • R&D must define its strategic ambitions and behaviours. What are we really trying to achieve and how should we behave to achieve them? 
  • Leadership needs to own the transformation process.  They must have a clear vision of what the transformation is supposed to do and make sure the business achieves it 
  • It is also R&D that provides the drive and vision for the transformation with the primary purpose of their sponsorship is to create organizational commitment and support, helping ensure transformation does do not fail 
  • Achieving a successful cultural transition requires R&D to drive the change management. Real Estate and Workplace will provide the framework, design & change expertise, and communications tools to support R&D’s transformation journey 
15:00
Turning Data into Decisions
The Digital Lab
15:00
Laura Williams, Decision Science Manager, GSK
John Egerton, Head of Sales, LabTwin
Giving Time Back to Science with Provision of Scientific Services
The Connected Lab
15:00
Richard Snell, Director, Global Scientific Services, GSK

Richard Snell, Director, Global Scientific Services, GSK

Business Strategy and Capability Delivery for the Lab of the Future at Takeda Pharmaceuticals
The Innovation Lab
15:00
Christoph Pistek, Head, Innovation & Technology Sciences, R&D, Takeda Pharmaceuticals
Designing the Lab of the Future
The Innovation Lab
15:00
Christiana Olaibi, Laboratory Process Consultant, CBRE
  • Lab design framework then and now
  • Automation in the lab vs “The manual lab”
  • Occupancy and equipment utilisation for the ideal workflow and lab design.
16:00
Tea Break and Exhibition
Plenary Sessions
16:00
16:30
The Digitization of AstraZeneca Labs
The Digital Lab
16:30
Amrik Mahal, Global Head, IT for Research, AstraZeneca
Robin Brouwer, IT lead for Global Labs, Early Science, AstraZeneca
Bringing Machine Learning in Lab Operations for Drug Discovery
The Connected Lab
16:30
Christophe Chabbert, Senior Scientist & Product Manager, Roche

Bringing Machine Learning in Lab Operations for Drug Discovery: The example of compound property predictors

Creating Space for Innovation at CSL Behring
The Innovation Lab
16:30
Vicky Pirzas, VP, Recombinant Product Development, CSL Behring
17:30
LiveLab Working Groups
Plenary Sessions
17:30 BST
Start time: 12:40 CDT | 13:40 EDT | 18:40 BST | 19:40 CEST |
18:15
Networking Drinks Reception
Plenary Sessions
18:15
09:00
Keynote Address: The Novartis Research Data Strategy- Data Culture, Data Management, Data Science and Data Enterprise
Plenary Sessions
09:00
Philippe Marc, Executive Director, Global Head of Integrated Data Sciences, Novartis Institutes for BioMedical Research
10:40
Coffee Break & Exhibition
Plenary Sessions
10:40 BST
Start time: 11:50 CDT | 12:50 EDT | 17:50 BST | 18:50 CEST |
09:50
Keynote Address: The Sustainable Lab is the Lab of the Future
Plenary Sessions
09:50
Penny James, Chief Operating Officer for Biopharma R&D, AstraZeneca
Priya Vijayakumar, CEO, Watt IQ

The Sustainable Lab is the Lab of the Future

  • When we envision the ‘Lab of the Future’ we know this requires increasing innovation, automation and technology
  • To deliver ‘Sustainable Business Growth’ we look for solutions to increase productivity whilst at the same time reducing the amount we consume – in energy, resources and space
  • These 2 goals can be aligned and achieved by embedding sustainability and digitization into every area of our labs

Penny James, Chief Operating Officer for Biopharma R&D, AstraZeneca

Digitalization & Connectivity on the Path to Net Zero

  • Reimagining Asset Intelligence
  • Emissions: The Energy Frenzy
  • Emissions: The Other 85% of Assets
  • Democratization of Data

Priya Vijayakumar, CEO, Watt IQ

11:20
Digitalization in the Clinical Laboratory
The Digital Lab
11:20
Mathew Divine, Head of Digital Lab in Clinical Development & Operations, Boehringer Ingelheim
Lab Automation – Delivering Solutions and Future Directions
The Connected Lab
11:20
Philip Hopcroft, Associate Principal Scientist, AstraZeneca
Sascha Fischer, Business Development Manager, Automation, Genedata
Strategic Procurement in support of the Scientist: The Roche Journey Towards a Progressive Procurement Value Chain
The Innovation Lab
11:20
Francesca Nani, Sr. Market Solutions Manager - R&D Solutions, Roche
12:20
Regulatory Document Automation
The Digital Lab
12:20
Pamela Sepulveda, Director, Digital Strategy, Pfizer
Justin Kenagy, Director, Digital Business Operations, Pfizer
The Design and Operational Rollout of a Connected Health Analytics Platform
The Connected Lab
12:20
Oliver Meier, Head Strategy, Design and Operations, Connected Health, Novartis
Using Robotics and Automation to Invent, Improve and Design Concepts that Reduce Human Interventions and Remove Repetitive Work
The Connected Lab
12:20
James Love, Vice President, Automation and Process Optimization, Novo Nordisk
  • High throughput automated protein production
  • Automation of closed loop optimization for biologics
  • Building and deploying your own automated solutions
  • Barriers to lab of the future, a personal viewpoint
Cancer Research Horizons – Driving innovations in cancer drug discovery through collaborative alliances with industry and academia
The Innovation Lab
12:20
Jennifer McKelvie, Head of Portfolio and Data Operations, Cancer Research Horizons (CRUK)
Collaborative Drug Design In Virtual Reality At UCB
The Innovation Lab
12:20
Sasker Grootjans, New Medicines IT Sr. Project Manager, UCB
13:00
Lunch & Exhibition
Plenary Sessions
13:00
14:00
The Pistoia Alliance Unified Integrated Knowledge Base
The Digital Lab
14:00
Anca Ciobanu, Lab of the Future Lead, Pistoia Alliance

Creating a community-led knowledge base for R&D Application, Instrument, Data, and Services Integrations

Interoperability Standards as an Enabler in the Digital Lab of the Future
The Connected Lab
14:00
Andrew Mitchell, Data Manager, Unilever
Burkhard Schaefer, AnIML User Group, SiLA
James Love, Vice President, Automation and Process Optimization, Novo Nordisk
Patrick Courtney, Director, SiLA
The Next Generation Innovation – Start-ups panel
The Innovation Lab
14:00
Martin Winter, Founder, Lab Automation Network